Fu Lilan, Xie Fei, Sun Penghui, Dong Ye, Zhou Kemin, Jiang Li, Wu Ruihe, Han Yanjiang, Wu Hubing, Tang Ganghua, Zhou Wenlan
Department of Nuclear Medicine, NanFang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
GDMPA Key Laboratory for Quality Control and Evaluation of Radiopharmaceuticals, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
Eur J Nucl Med Mol Imaging. 2025 May 19. doi: 10.1007/s00259-025-07325-9.
This study was conducted to explore the predictive value of PET parameters derived from F-FAPI-42 PET/CT in assessing lymphovascular and/or perineural invasion (LVI/PNI) in gastric cancer (GC) patients.
72 GC patients who underwent F-FAPI-42 PET/CT prior to surgical resection were included. Clinicopathological factors and PET parameters were collected and analyzed in LVI/PNI-negative and LVI/PNI-positive groups. The predictive value of PET parameters for LVI/PNI status was evaluated using the receiver operating characteristic (ROC) curve. A nomogram was developed using significant predictors from multivariate stepwise regression analysis and its performance was assessed by decision curve analysis (DCA).
Univariate analysis indicated a significant association between LVI/PNI status and PET parameters (SUVmax, SUVmean, and TBR) (all p < 0.001). The area under the ROC curve (AUC) values for predicting LVI/PNI were 0.932 [95% CI (0.877-0.987)] for SUVmax, 0.923 [95% CI (0.861-0.984)] for SUVmean, and 0.925 [95% CI (0.865-0.985)] for TBR. The optimal cutoff values for prediction, along with their corresponding sensitivity and specificity, were 3.86 (93.3% and 81.5%) for SUVmax, 2.04 (93.3% and 81.5%) for SUVmean, and 9.75 (91.1% and 81.5%) for TBR. Multivariate analysis identified histological grade and SUVmax as independent risk factors for LVI/PNI prediction. Our nomogram had good discriminatory ability (AUC = 0.934) and offered net benefits in predicting LVI/PNI status by DCA.
This study demonstrates that FAPI uptake parameters exhibit an exceptionally high capacity and serve as a noninvasive preoperative tool for predicting LVI/PNI status in GC, with SUVmax emerging as the most suitable predictive indicator.
本研究旨在探讨F-FAPI-42 PET/CT衍生的PET参数在评估胃癌(GC)患者淋巴管和/或神经周围侵犯(LVI/PNI)方面的预测价值。
纳入72例手术切除前接受F-FAPI-42 PET/CT检查的GC患者。收集并分析LVI/PNI阴性和阳性组的临床病理因素及PET参数。采用受试者工作特征(ROC)曲线评估PET参数对LVI/PNI状态的预测价值。使用多因素逐步回归分析中的显著预测因子构建列线图,并通过决策曲线分析(DCA)评估其性能。
单因素分析表明LVI/PNI状态与PET参数(SUVmax、SUVmean和TBR)之间存在显著关联(所有p < 0.001)。预测LVI/PNI的ROC曲线下面积(AUC)值,SUVmax为0.932 [95% CI(0.877 - 0.987)],SUVmean为0.923 [95% CI(0.861 - 0.984)],TBR为0.925 [95% CI(0.865 - 0.985)]。预测的最佳截断值及其相应的敏感性和特异性分别为,SUVmax为3.86(93.3%和81.5%),SUVmean为2.04(93.3%和81.5%),TBR为9.75(91.1%和81.5%)。多因素分析确定组织学分级和SUVmax为LVI/PNI预测的独立危险因素。我们的列线图具有良好的鉴别能力(AUC = 0.934),并且通过DCA在预测LVI/PNI状态方面提供了净效益。
本研究表明FAPI摄取参数具有极高的预测能力,可作为预测GC患者LVI/PNI状态的无创术前工具,其中SUVmax是最合适的预测指标。